Application of interpretable machine learning algorithms to predict macroangiopathy risk in Chinese patients with type 2 diabetes mellitus
Open Access
- 12 May 2025
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-14
Abstract
Macrovascular complications are leading causes of morbidity and mortality in patients with type 2 diabetes mellitus (T2DM), yet early diagnosis of cardiovascular disease (CVD) in this population remains clinically challenging. This study aims to develop a machine learning model that can accurately predict diabetic macroangiopathy in Chinese patients. A retrospective cross-sectional analytical study was conducted on 1566 hospitalized patients with T2DM. Feature selection was performed using recursive feature elimination (RFE) within the mlr3 framework. Model performance was benchmarked using 29 machine learning (ML) models, with the ranger model selected for its superior performance. Hyperparameters were optimized through grid search and 5-fold cross-validation. Model interpretability was enhanced using SHAP values and PDPs. An external validation set of 106 patients was used to test the model. Key predictive variables identified included the duration of T2DM, age, fibrinogen, and serum urea nitrogen. The predictive model for macroangiopathy was established and showed good discrimination performance with an accuracy of 0.716 and an AUC of 0.777 in the training set. Validation on the external dataset confirmed its robustness with an AUC of 0.745. This study establish an approach based on machine learning algorithm in features selection and the development of prediction tools for diabetic macroangiopathy.Keywords
Funding Information
- The National Natural Science Foundation of China (82102281)
- the Natural Scientific Foundation of Hunan Province (2021JJ40867, 2021JJ40893)
- the Scientific Research Fund of Hunan Province Health Commission (202101062143, 202101062143)
This publication has 28 references indexed in Scilit:
- The current landscape for diabetes treatment: Preventing diabetes-associated CV riskAtherosclerosis, 2024
- Early onset type 2 diabetes mellitus: an updateEndocrine, 2024
- Effect of metformin (vs. placebo or sulfonylurea) on all-cause and cardiovascular mortality and incident cardiovascular events in patients with diabetes: an umbrella review of systematic reviews with meta-analysisJournal of Diabetes & Metabolic Disorders, 2023
- Fibrinogen and fibrin: synthesis, structure, and function in health and diseaseJournal of Thrombosis and Haemostasis, 2023
- IDF diabetes Atlas: Global estimates of undiagnosed diabetes in adults for 2021Diabetes Research and Clinical Practice, 2022
- Prevalence and Treatment of Diabetes in China, 2013-2018JAMA, 2021
- Renal status in elderly patients with type 2 diabetesClinical and Experimental Nephrology, 2019
- High fibrinogen level is an independent predictor of presence and extent of coronary artery disease among Italian populationJournal of Thrombosis and Thrombolysis, 2010
- Elevated blood urea nitrogen-to-creatinine ratio increased the risk of hospitalization and all-cause death in patients with chronic heart failureClinical Research in Cardiology, 2009
- Elevated fibrinogen levels and subsequent subclinical atherosclerosis: The CARDIA StudyAtherosclerosis, 2009